Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 429 publications
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: August 27, 2025
Oncolytic Herpes Simplex Virus Therapy: Latest Advances, Core Challenges, and Future Outlook.
Journal: Vaccines
Published: July 09, 2025
Quantitative habitat concentration analysis of triple negative breast cancer on MRI correlates with pathologic response to combination neoadjuvant immuno/chemotherapy.
Journal: Clinical imaging
Published: June 27, 2025
Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential.
Journal: Frontiers in microbiology
Published: June 04, 2025
In Situ Vaccines in the Era of Cancer Immunotherapy: Conceptual Innovation and Clinical Translation.
In Situ Vaccines in the Era of Cancer Immunotherapy: Conceptual Innovation and Clinical Translation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 29, 2025
Clinical Pharmacology Characterization of the First-In-Class Oncolytic Viral Therapy T-VEC in Adults and Pediatric Subjects.
Journal: Journal of clinical pharmacology
Published: May 27, 2025
Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review.
Journal: Vaccines
Published: May 27, 2025
Talimogene laherparepvec induced bullous pemphigoid.
Journal: JAAD case reports
Published: May 26, 2025
Systemic Therapy for Melanoma: What Surgeons Need to Know.
Journal: Surgical oncology clinics of North America
Published: May 24, 2025
Anatomic Location Predicts Response Rates: Real World Outcomes with Over 1,100 Cycles of Talimogene Laherparepvec (TVEC) Description: A Retrospective Review of a Prospectively Maintained Database.
Journal: Annals of surgery
Published: April 29, 2025
Analysis of talimogene laherparepvec (T-VEC) safety signals from food and drug administration adverse event reporting system (FAERS).
Journal: European journal of pharmacology
Published: April 12, 2025
Oncolytic HSV and cancer drug interactions: Current clinical status and future directions.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 17, 2025
Last Updated: 10/31/2025